| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 21.98▼ | 21.96▼ | 21.87▲ | 21.73▲ | 19.36▲ |
| MA10 | 21.93▼ | 21.91▼ | 21.80▲ | 21.54▲ | 20.32▲ |
| MA20 | 21.95▼ | 21.83▲ | 21.68▲ | 19.40▲ | 21.68▲ |
| MA50 | 21.85▲ | 21.60▲ | 21.49▲ | 20.19▲ | 24.48▼ |
| MA100 | 21.78▲ | 21.48▲ | 20.38▲ | 21.61▲ | N/A |
| MA200 | 21.61▲ | 19.98▲ | 18.83▲ | 24.41▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | 0.005▲ | 0.006▲ | 0.363▲ | 0.018▲ |
| RSI | 47.993▼ | 52.918▲ | 54.860▲ | 60.452▲ | 49.288▼ |
| STOCH | 56.336 | 71.689 | 72.920 | 60.033 | 46.254 |
| WILL %R | -80.392▼ | -36.620 | -27.513 | -27.697 | -29.570 |
| CCI | -55.021 | 44.645 | 102.040▲ | 73.733 | 20.238 |
|
Tuesday, April 29, 2025 04:01 AM
Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 22.14 | 22.14 | 21.83 | 21.88 | 45,185 |
| 01/05/25 | 21.60 | 22.05 | 21.00 | 21.70 | 280,459 |
| 30/04/25 | 21.75 | 22.03 | 20.805 | 21.85 | 262,782 |
| 29/04/25 | 21.29 | 21.845 | 20.755 | 21.76 | 165,560 |
| 28/04/25 | 20.77 | 22.20 | 20.77 | 21.45 | 347,325 |
| 25/04/25 | 20.91 | 21.715 | 20.64 | 21.67 | 198,482 |
| 24/04/25 | 21.55 | 22.04 | 20.86 | 21.23 | 335,240 |
| 23/04/25 | 22.63 | 23.69 | 21.23 | 21.56 | 247,843 |
| 22/04/25 | 20.78 | 21.955 | 20.37 | 21.87 | 282,090 |
| 21/04/25 | 19.17 | 21.40 | 18.65 | 20.45 | 429,594 |
|
|
||||
|
|
||||
|
|